S2Medical AB (S2M) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.068x

Based on the latest financial reports, S2Medical AB (S2M) has a cash flow conversion efficiency ratio of 0.068x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.29 Million ≈ $138.82K USD) by net assets (Skr18.88 Million ≈ $2.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

S2Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how S2Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read S2Medical AB (S2M) financial obligations for a breakdown of total debt and financial obligations.

S2Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of S2Medical AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Panthera Resources PLC
LSE:PAT
-0.312x
Gyldendal A/S
CO:GYLD-B
0.262x
Oxbridge Re Holdings Equity Warrant
NASDAQ:OXBRW
0.067x
Ivory Properties Group Bhd
KLSE:5175
0.629x
EPE Special Opportunities Limited
LSE:ESO
-0.015x
Cora Gold Limited
LSE:CORA
-0.013x
Panther Securities P L C
LSE:PNS
0.016x
Ortel Communications Limited
NSE:ORTEL
-0.035x

Annual Cash Flow Conversion Efficiency for S2Medical AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of S2Medical AB from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see S2M market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr9.88 Million
≈ $1.06 Million
Skr675.00K
≈ $72.64K
0.068x -83.97%
2024-12-31 Skr11.80 Million
≈ $1.27 Million
Skr5.03 Million
≈ $541.40K
0.426x +104.28%
2023-12-31 Skr1.66 Million
≈ $178.42K
Skr-16.52 Million
≈ $-1.78 Million
-9.964x -150.39%
2022-12-31 Skr7.07 Million
≈ $760.76K
Skr-28.13 Million
≈ $-3.03 Million
-3.979x -197.08%
2021-12-31 Skr14.68 Million
≈ $1.58 Million
Skr-19.67 Million
≈ $-2.12 Million
-1.339x -244.25%
2020-12-31 Skr32.77 Million
≈ $3.53 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.389x +42.87%
2019-12-31 Skr25.11 Million
≈ $2.70 Million
Skr-17.10 Million
≈ $-1.84 Million
-0.681x -132.57%
2018-12-31 Skr43.55 Million
≈ $4.69 Million
Skr-12.75 Million
≈ $-1.37 Million
-0.293x +63.05%
2017-12-31 Skr7.38 Million
≈ $793.67K
Skr-5.85 Million
≈ $-629.12K
-0.793x +28.05%
2016-12-31 Skr2.75 Million
≈ $296.05K
Skr-3.03 Million
≈ $-326.18K
-1.102x --

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$611.88K
Skr5.69 Million SEK
Market Cap Rank
#30463 Global
#721 in Sweden
Share Price
Skr0.01
Change (1 day)
-5.56%
52-Week Range
Skr0.01 - Skr0.03
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more